Xencor (XNCR) Short-term Investments (2015 - 2026)

Xencor's (XNCR) quarterly Short-term Investments came in at $370.2 million in Q1 2026, up 657.53% year-on-year from $48.9 million in Q1 2025, and down 2.87% on a QoQ basis from $381.2 million in Q4 2025.

Xencor (XNCR) Short-term Investments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has 12 years of Short-term Investments data on file, last reported at $370.2 million in Q1 2026.

  • On a quarterly basis, Short-term Investments rose 657.53% year-over-year to $370.2 million in Q1 2026; TTM through Mar 2026 was $370.2 million, a 657.53% increase from a year earlier, with the FY2025 full-year figure at $381.2 million, down 6.8% from the prior year.
  • Short-term Investments for Q1 2026 stood at $370.2 million, down from $381.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for XNCR reached as high as $497.7 million in Q4 2023 and fell as low as $26.9 million in Q2 2022.
  • Historically, Short-term Investments has averaged $193.3 million across 5 years, with a median of $48.9 million in 2025.
  • Across the five-year window, Short-term Investments slumped 90.94% in 2022 and soared 1182.71% in 2023, its largest moves.
  • Year by year, Short-term Investments stood at $42.4 million in 2022, then jumped by 1073.02% to $497.7 million in 2023, then slipped by 17.83% to $409.0 million in 2024, then dropped by 6.8% to $381.2 million in 2025, then fell by 2.87% to $370.2 million in 2026.
  • Per Business Quant data, the three most recent Short-term Investments figures were $370.2 million in Q1 2026, $381.2 million in Q4 2025, and $84.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn
10 Xencor 1.49 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 370.21 Mn
Dec 31, 2025 381.16 Mn
Sep 30, 2025 84.26 Mn
Jun 30, 2025 358.98 Mn
Mar 31, 2025 48.87 Mn
Dec 31, 2024 408.97 Mn
Sep 30, 2024 435.04 Mn
Jun 30, 2024 28.27 Mn
Mar 31, 2024 44.54 Mn
Dec 31, 2023 497.73 Mn
Sep 30, 2023 412.83 Mn
Jun 30, 2023 40.00 Mn
Mar 31, 2023 39.71 Mn
Dec 31, 2022 42.43 Mn
Sep 30, 2022 32.18 Mn
Jun 30, 2022 26.89 Mn
Mar 31, 2022 33.43 Mn
Dec 31, 2021 36.86 Mn
Sep 30, 2021 47.58 Mn
Jun 30, 2021 45.23 Mn